InsidersTradesSigma
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by Shabbir Anik. Director active across 1 company, notably Sutro Biopharma, INC.. In total, 7 reports have been logged. History available since 24 September 2021. The latest transaction was filed on 27 January 2023 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
7 of 7 declarations
Shabbir Anik is a director at Sutro Biopharma, INC.